ImaRx Therapeutics (Urokinase Business) is Biotechnology in United States that focus on manufacturer business. They cover business area such as manufacturer, bio, pharmaceutical product, treatment, acute massive pulmonary embolism.
-
Manufacturer
-
6860 Lexington Avenue
Suite 120
Los Angeles, CA 90038
United States
Private
manufacturerbiopharmaceutical producttreatmentacute massive pulmonary embolism
* We use standard office opening hours in near ImaRx Therapeutics (Urokinase Business)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ImaRx Therapeutics (Urokinase Business) is Biotechnology business from United States that founded in - ( years old in ), ImaRx Therapeutics (Urokinase Business) business is focusing on Manufacturer.
ImaRx Therapeutics (Urokinase Business) headquarter office and corporate office address is located in 6860 Lexington Avenue Suite 120 Los Angeles, CA 90038 United States.
ImaRx Therapeutics (Urokinase Business) was founded in United States.
In , ImaRx Therapeutics (Urokinase Business) is currently focus on manufacturer sector.
Above is snippet of Google Trends for "manufacturer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ImaRx Therapeutics (Urokinase Business), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
